The present invention relates to compounds of the formula I:
##STR1##
where Ring A is a thiazole, oxazole, imidazole or pyrazole and the substituents
are as described in the specification, and pharmaceutically acceptable salts thereof.
The compounds inhibit bacterial gyrase activity and therefore are useful for treating
bacterial infections in mammals.